Clinical Trial Update: Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial) [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating atezolizumab in advanced non-small cell lung cancer with rare histologies (CHANCE trial) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED